| Authors: |
Schöll M; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Gothenburg, Sweden; Dementia Research Centre, Queen Square Institute of Neurology, University College London, London, UK; Department of Neuropsychiatry, Sahlgrenska University Hospital, Mölndal, Sweden., Vrillon A; French Institute of Health and Medical Research (Inserm), Paris, France., Ikeuchi T; Niigata University Brain Research Institute, Niigata, Japan., Quevenco FC; Eli Lilly and Company, Indianapolis, IN, United States., Iaccarino L; Eli Lilly and Company, Indianapolis, IN, United States., Vasileva-Metodiev SZ; Eli Lilly and Company, Indianapolis, IN, United States., Burnham SC; Eli Lilly and Company, Indianapolis, IN, United States., Hendrix J; Eli Lilly and Company, Indianapolis, IN, United States., Epelbaum S; Eli Lilly and Company, Indianapolis, IN, United States., Zetterberg H; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK; UK Dementia Research Institute at UCL, London, UK; Hong Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, China; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA., Palmqvist S; Clinical Memory Research Unit, Clinical Sciences in Malmö, Lund University, Lund, Sweden; Memory Clinic, Skåne University Hospital, Sweden. Electronic address: sebastian.palmqvist@med.lu.se. |
